Last 7 days
5.0%
Last 30 days
-0.2%
Last 90 days
-7.4%
Trailing 12 Months
17.4%
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
ITW | 73.2B | 15.9B | 2.88% | 13.29% | 24.11 | 4.59 | 10.22% | 12.62% |
IR | 23.2B | 5.9B | -1.27% | 12.95% | 38.39 | 3.92 | 14.83% | 7.50% |
XYL | 18.5B | 5.5B | -0.24% | 17.36% | 51.98 | 3.34 | 6.29% | -16.86% |
IEX | 17.1B | 3.2B | 0.88% | 17.28% | 29.16 | 5.38 | 15.09% | 30.60% |
GGG | 12.0B | 2.1B | 3.18% | 2.14% | 26.12 | 5.61 | 7.84% | 4.72% |
MID-CAP | ||||||||
DCI | 7.9B | 3.4B | 1.98% | 21.97% | 22.14 | 2.31 | 10.23% | 12.47% |
ITT | 7.0B | 3.0B | -7.00% | 9.63% | 19.05 | 2.34 | 8.05% | 16.03% |
FLS | 4.4B | 3.6B | -3.06% | -3.60% | 23.3 | 1.22 | 2.09% | 49.85% |
SMALL-CAP | ||||||||
ERII | 1.2B | 125.6M | 0.18% | 8.12% | 51.56 | 9.87 | 20.87% | 68.54% |
GRC | 633.8M | 521.0M | -12.81% | -32.20% | 56.62 | 1.22 | 37.72% | -62.50% |
TWIN | 131.4M | 254.5M | -10.95% | -42.15% | 14.25 | 0.52 | 9.95% | 139.59% |
MNTX | 104.2M | 273.9M | 1.17% | -29.72% | -21.25 | 0.38 | 29.46% | -7.17% |
NNBR | 43.0M | 491.1M | -46.74% | -65.73% | -3.16 | 0.09 | 1.00% | -108.69% |
Income Statement (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Revenue | 3.4% | 5,522 | 5,339 | 5,224 | 5,211 | 5,195 |
Cost Of Revenue | 3.1% | 3,438 | 3,335 | 3,272 | 3,259 | 3,220 |
Gross Profit | 4.0% | 2,084 | 2,004 | 1,952 | 1,952 | 1,975 |
S&GA Expenses | 1.2% | 1,227 | 1,213 | 1,192 | 1,182 | 1,179 |
R&D Expenses | 1.0% | 206 | 204 | 206 | 206 | 204 |
EBITDA | 11.7% | 601 | 538 | 667 | 679 | - |
EBITDA Margin | 8.0% | 0.11* | 0.10* | 0.13* | 0.14* | - |
Earnings Before Taxes | 16.7% | 440 | 377 | 493 | 495 | 511 |
EBT Margin | 12.8% | 0.08* | 0.07* | 0.09* | 0.10* | - |
Interest Expenses | 0% | 50.00 | 50.00 | 59.00 | 68.00 | 76.00 |
Net Income | 11.3% | 355 | 319 | 421 | 422 | 427 |
Net Income Margin | 7.6% | 0.06* | 0.06* | 0.08* | 0.08* | - |
Free Cahsflow | 31.3% | 596 | 454 | 364 | 483 | - |
Balance Sheet | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Assets | -1.9% | 7,952 | 8,106 | 8,189 | 8,219 | 8,276 |
Current Assets | -5.6% | 3,012 | 3,191 | 3,174 | 3,118 | 3,160 |
Cash Equivalents | -20.4% | 944 | 1,186 | 1,113 | 1,117 | 1,349 |
Inventory | -4.5% | 799 | 837 | 852 | 804 | 700 |
Net PPE | 7.7% | 630 | 585 | 608 | 636 | 644 |
Goodwill | 3.1% | 2,719 | 2,637 | 2,714 | 2,782 | 2,792 |
Liabilities | -8.9% | 4,449 | 4,884 | 4,986 | 5,013 | 5,050 |
Current Liabilities | -17.6% | 1,590 | 1,929 | 1,951 | 1,920 | 1,391 |
LT Debt, Non Current | 0% | 1,880 | 1,880 | 1,879 | 1,878 | 2,440 |
Shareholder's Equity | 8.7% | 3,494 | 3,215 | 3,203 | 3,206 | 3,218 |
Retained Earnings | 4.3% | 2,292 | 2,197 | 2,238 | 2,181 | 2,154 |
Additional Paid-In Capital | 0.5% | 2,134 | 2,123 | 2,111 | 2,099 | 2,089 |
Shares Outstanding | 0.0% | 180 | 180 | 180 | - | - |
Minority Interest | 28.6% | 9.00 | 7.00 | 8.00 | 8.00 | 8.00 |
Cashflow (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Cashflow From Operations | 31.3% | 596 | 454 | 364 | 483 | 538 |
Share Based Compensation | 2.8% | 37.00 | 36.00 | 34.00 | 33.00 | 33.00 |
Cashflow From Investing | 1.0% | -191 | -193 | -198 | -195 | -183 |
Cashflow From Financing | -205.0% | -790 | -259 | -851 | -846 | -855 |
Dividend Payments | 1.4% | 217 | 214 | 211 | 207 | 203 |
Buy Backs | 0% | 52.00 | 52.00 | 52.00 | 52.00 | 68.00 |
55%
37.7%
12.3%
Y-axis is the maximum loss one would have experienced if Xylem was unfortunately bought at previous high price.
15.6%
15.4%
7.1%
16.9%
FIve years rolling returns for Xylem.
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-03-29 | Diametric Capital, LP | sold off | -100 | -1,334,000 | - | -% |
2023-03-23 | MetLife Investment Management, LLC | reduced | -1.64 | 1,044,810 | 5,311,560 | 0.04% |
2023-03-23 | ETF MANAGERS GROUP, LLC | added | 4.22 | 224,346 | 928,346 | 0.04% |
2023-03-17 | American Portfolios Advisors | unchanged | - | 4,968 | 47,274 | -% |
2023-03-15 | B. Riley Wealth Advisors, Inc. | added | 24.2 | 533,264 | 1,467,260 | 0.04% |
2023-03-10 | VICTORY CAPITAL MANAGEMENT INC | added | 2.88 | 75,977,200 | 327,482,000 | 0.36% |
2023-03-10 | BAILLIE GIFFORD & CO | added | 6.19 | 89,099,300 | 348,102,000 | 0.36% |
2023-03-08 | Capital Asset Advisory Services LLC | reduced | -18.92 | 27,695 | 652,695 | 0.05% |
2023-03-06 | Rockefeller Capital Management L.P. | reduced | -13.16 | 749,000 | 8,296,000 | 0.04% |
2023-03-03 | TIAA, FSB | new | - | 204,776 | 204,776 | -% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 14, 2023 | aristotle capital management, llc | 5.59% | 10,076,810 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 11.67% | 21,037,631 | SC 13G/A | |
Jan 24, 2023 | blackrock inc. | 11.2% | 20,207,719 | SC 13G/A | |
Feb 14, 2022 | aristotle capital management, llc | 5.89% | 10,627,194 | SC 13G/A | |
Jan 27, 2022 | blackrock inc. | 10.0% | 18,052,578 | SC 13G/A | |
Jan 26, 2022 | blackrock inc. | 10.0% | 18,052,578 | SC 13G/A | |
Feb 16, 2021 | price t rowe associates inc /md/ | 0.5% | 944,169 | SC 13G/A | |
Feb 10, 2021 | vanguard group inc | 10.35% | 18,653,103 | SC 13G/A | |
Feb 02, 2021 | aristotle capital management, llc | 5.03% | 9,073,140 | SC 13G | |
Jan 27, 2021 | blackrock inc. | 10.1% | 18,252,469 | SC 13G/A |
Fair Value | Very Pessimistic | Pessimistic | Base Case | Optimistic | Very Optimistic |
---|---|---|---|---|---|
Very Low Inflation | 24.53 -76.04% | 31.68 -69.06% | 43.60 -57.42% | 65.37 -36.16% | 81.39 -20.52% |
Current Inflation | 21.00 -79.49% | 24.68 -75.90% | 35.23 -65.60% | 56.42 -44.90% | 69.53 -32.10% |
Very High Inflation | 20.75 -79.74% | 25.66 -74.94% | 33.30 -67.48% | 47.79 -53.33% | 58.14 -43.22% |
Date Filed | Form Type | Document | |
---|---|---|---|
Mar 15, 2023 | 4 | Insider Trading | |
Mar 13, 2023 | 144 | Notice of Insider Sale Intent | |
Mar 10, 2023 | 4 | Insider Trading | |
Mar 09, 2023 | 3 | Insider Trading | |
Mar 09, 2023 | 4 | Insider Trading | |
Mar 09, 2023 | S-4 | Mergers and Acquisition | |
Mar 03, 2023 | 4 | Insider Trading | |
Mar 03, 2023 | 4 | Insider Trading | |
Mar 03, 2023 | 4 | Insider Trading | |
Mar 03, 2023 | 4 | Insider Trading |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-03-13 | Decker Patrick | acquired | 2,072,330 | 36.81 | 56,298 | president & ceo |
2023-03-13 | Decker Patrick | sold | -5,527,840 | 98.1889 | -56,298 | president & ceo |
2023-03-09 | ELLIS EARL RAY | acquired | - | - | 249 | - |
2023-03-07 | Toussaint Claudia S | gifted | - | - | -4,977 | svp, cpso |
2023-03-02 | Yarkadas Hayati | sold | -1,601,010 | 100 | -15,942 | svp & president, eu, wi & gls |
2023-03-02 | Yarkadas Hayati | acquired | 823,117 | 74.0813 | 11,111 | svp & president, eu, wi & gls |
2023-03-01 | Pine Matthew Francis | sold (taxes) | -80,265 | 101 | -794 | coo |
2023-03-01 | Yarkadas Hayati | acquired | - | - | 4,204 | svp & president, eu, wi & gls |
2023-03-01 | Yarkadas Hayati | sold (taxes) | -10,311 | 101 | -102 | svp & president, eu, wi & gls |
2023-03-01 | Decker Patrick | sold (taxes) | -558,219 | 101 | -5,522 | president & ceo |
Consolidated Income Statements - USD ($) shares in Thousands, $ in Millions | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Income Statement [Abstract] | |||
Revenue | $ 5,522 | $ 5,195 | $ 4,876 |
Cost of revenue | 3,438 | 3,220 | 3,046 |
Gross profit | 2,084 | 1,975 | 1,830 |
Selling, general and administrative expenses | 1,227 | 1,179 | 1,143 |
Research and development expenses | 206 | 204 | 187 |
Restructuring and asset impairment charges | 29 | 7 | 75 |
Goodwill, Impairment Loss | 0 | 0 | 58 |
Operating income | 622 | 585 | 367 |
Interest expense | 50 | 76 | 77 |
U.K. pension settlement expense | (140) | 0 | 0 |
Other non-operating income (expense), net | 7 | 0 | (5) |
Gain on sale of businesses | 1 | 2 | 0 |
Income before taxes | 440 | 511 | 285 |
Income tax expense | 85 | 84 | 31 |
Net income | $ 355 | $ 427 | $ 254 |
Earnings per share: | |||
Basic (in dollars per share) | $ 1.97 | $ 2.37 | $ 1.41 |
Diluted (in dollars per share) | $ 1.96 | $ 2.35 | $ 1.40 |
Basic (in shares) | 180,217 | 180,247 | 180,116 |
Weighted average common shares outstanding — Diluted | 180,979 | 181,526 | 181,099 |
Dividends declared per share (in usd per share) | $ 1.20 | $ 1.12 | $ 1.04 |
Consolidated Balance Sheets - USD ($) $ in Millions | Dec. 31, 2022 | Dec. 31, 2021 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 944 | $ 1,349 |
Receivables, less allowances for discounts, returns and credit losses of $50 and $44 in 2022 and 2021, respectively | 1,096 | 953 |
Inventories | 799 | 700 |
Prepaid and other current assets | 173 | 158 |
Total current assets | 3,012 | 3,160 |
Property, plant and equipment, net | 630 | 644 |
Goodwill | 2,719 | 2,792 |
Other intangible assets, net | 930 | 1,016 |
Other non-current assets | 661 | 664 |
Total assets | 7,952 | 8,276 |
Current liabilities: | ||
Accounts payable | 723 | 639 |
Accrued and other current liabilities | 867 | 752 |
Total current liabilities | 1,590 | 1,391 |
Long-term debt, net | 1,880 | 2,440 |
Accrued post-retirement benefit obligations | 286 | 438 |
Deferred income tax liabilities | 222 | 287 |
Other non-current accrued liabilities | 471 | 494 |
Total liabilities | 4,449 | 5,050 |
Commitment and Contingencies (Note 19) | ||
Common stock — par value $0.01 per share: | ||
Authorized 750.0 shares, issued 196.0 and 195.6 shares in 2022 and 2021, respectively | 2 | 2 |
Capital in excess of par value | 2,134 | 2,089 |
Retained earnings | 2,292 | 2,154 |
Treasury stock – at cost 15.8 shares and 15.2 shares in 2022 and 2021, respectively | (708) | (656) |
Accumulated other comprehensive loss | (226) | (371) |
Total stockholders’ equity | 3,494 | 3,218 |
Non-controlling interest | 9 | 8 |
Total equity | 3,503 | 3,226 |
Total liabilities and stockholders’ equity | $ 7,952 | $ 8,276 |